3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Colonic Neoplasms
8
Stomach Neoplasms
6
Rectal Neoplasms
6
Ovarian Neoplasms
3
Liver Neoplasms
3
Neoplastic Cells, Circulating
2
Neoplasms
2
Gastrointestinal Stromal Tumors
2
Esophageal Neoplasms
2
Endometrial Neoplasms
2
Colorectal Neoplasms
2
Carcinoma, Renal Cell
2
Carcinoma, Hepatocellular
2
Uterine Cervical Neoplasms
1
Urinary Incontinence
1
Sexual Dysfunction, Physiological
1
Prostatic Neoplasms
1
Polycystic Ovary Syndrome
1
Pancreatic Neuroendocrine Tumors
1
Pancreatic Neoplasms
1
Obesity, Morbid
1
Myofibroma
1
Melanoma
1
Lymphatic Metastasis
1
Locally Advanced Pancreatic Adenocarcinoma
1
Liver Diseases
1
Kidney Neoplasms
1
Gynecological Cancer
1
Genital Diseases, Female
1
Gastrointestinal Neoplasms
1
Interventions
Uterine Myomectomy
3
Tourniquets
2
carbetocin
1
Vasopressins
1
Uterine Artery Embolization
1
Triptorelin Pamoate
1
Tranexamic Acid
1
Sevoflurane
1
Saline Solution
1
Respiration, Artificial
1
Remifentanil
1
Propofol
1
Population Groups
1
Nuclear Receptor Subfamily 4, Group A, Member 2
1
Morcellation
1
Misoprostol
1
Methylergonovine
1
Laparoscopy
1
Hysteroscopy
1
Hysterectomy, Vaginal
1
Hysterectomy
1
Ergonovine
1
Dexamethasone
1
Desflurane
1
Buspirone
1
Bupivacaine
1
Ascorbic Acid
1
Anesthesia, Spinal
1
Anesthesia, General
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Myofibroma
×
Laparoscopy
×
Clear all
NCT06067971
2025-09-12
ENDORA2
University Hospital, Clermont-Ferrand
Phase NA
Completed
40 enrolled